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SUMMARY
Optogenetic technologies employ light to control biological processes within targeted cells in vivo
with high temporal precision. Here, we show that application of molecular trafficking principles
can expand the optogenetic repertoire along several long-sought dimensions. Subcellular and
transcellular trafficking strategies now permit (1) optical regulation at the far-red/infrared border
and extension of optogenetic control across the entire visible spectrum, (2) increased potency of
optical inhibition without increased light power requirement (nanoampere-scale chloride-mediated
photocurrents that maintain the light sensitivity and reversible, step-like kinetic stability of earlier
tools), and (3) generalizable strategies for targeting cells based not only on genetic identity, but
also on morphology and tissue topology, to allow versatile targeting when promoters are not
known or in genetically intractable organisms. Together, these results illustrate use of cell-
biological principles to enable expansion of the versatile fast optogenetic technologies suitable for
intact-systems biology and behavior.
INTRODUCTION
A fundamental goal in biology is fast control of defined cells within functioning tissues.
Temporal precision of control is important since cells may carry out fundamentally different
computations and deliver different outputs depending on the timing and context of input
signals. For example, it is almost meaningless to ask the causal role of “activation” or
“inhibition” of a neuron type in the brain, since changes in context (Fleischmann et al.,
2008) or millisecond-scale shifts in timing (Bi and Poo, 1998; Silberberg et al., 2004) can
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change the magnitude or flip the sign of neuronal action on the circuit. Similarly, pancreatic
β cells execute synchronized oscillations in membrane potential resulting in pulsatile insulin
secretion with precise timing across the population of β cells that may be important for the
action of insulin on target tissues (Tengholm and Gylfe, 2009). Traditional genetics delivers
cell type-specific control if adequate targeting strategies exist, but genetic approaches lack
the temporal precision needed to control events with behaviorally or environmentally
relevant triggering and timing; moreover, pharmacological control strategies lack cell type-
specificity, temporal precision, or both. The general need to study molecular and cellular
events not only in reduced systems, but also within intact biological systems, has driven
recent awareness of the opportunities of fast control.
To enable temporally precise control of specific cell types within behaving animals, fast
“optogenetic” (Deisseroth et al., 2006) technologies have been developed involving single-
component light-responsive proteins that transduce brief pulses of light into well-defined
action potential trains and effector functions in vivo (Boyden et al., 2005; Zhang et al.,
2007a, 2007b). Through the use of optogenetics, precisely timed gain-of-function or loss-of-
function of specified events can be achieved in targeted cells of freely moving mammals and
other animals (Adamantidis et al., 2007). For example, we have found that direct light-
triggered excitation of cellular electrical activity (depolarization and precisely timed action
potentials) can be achieved via expression of the microbial opsin genes encoding
Chlamydomonas channelrhodopsin-2 (ChR2) (Boyden et al., 2005) or Volvox
channelrhodopsin-1 (VChR1) (Zhang et al., 2008). On the other hand, direct light-triggered
inhibition of electrical activity (precisely timed hyperpolarization) can be achieved via
expression of the Natronomonas halorhodopsin (NpHR) in vivo (Zhang et al., 2007a; Han
and Boyden, 2007; Gradinaru et al., 2008); this halorhodopsin was selected for its step-like
and highly stable photocurrents compared with other microbial generators of inhibitory
current (Zhang et al., 2007a). The halorhodopsin achieves inhibition by pumping into
neurons an ion (chloride) that constitutes part of the natural mechanism of neuronal
inhibition, and neurons are therefore well designed to process chloride influx (Zhang et al.,
2007a); microbial proton pumps additionally can be used to achieve outward currents (Chow
et al., 2010). Finally, more subtle (but still temporally precise) optical modulatory strategies
are also possible, including changes in the input-output relationships of targeted cells via
expression of engineered step function opsins, or “SFOs,” that alter excitability (Berndt et
al., 2009), and fast selective control of modulatory Gs or Gq signaling using synthetic
rhodopsin/G protein-coupled receptor chimeras (optoXRs) (Airan et al., 2009). This
collection of tools, along with the development of versatile devices to deliver light in vivo
(Aravanis et al., 2007; Adamantidis et al., 2007; Gradinaru et al., 2007), has enabled
widespread application of optogenetics.
To further expand the optogenetic toolbox, we have previously carried out genomic
screening strategies to successfully identify and validate novel classes of opsins for
optogenetic control (Zhang et al., 2007a, 2008) and carried out rationally designed
mutagenesis to achieve new classes of opsin functionality (Berndt et al., 2009; Gunaydin et
al., 2010). Here, we apply a third type of intervention, namely application of molecular
trafficking strategies, to derive a panel of tools that both quantitatively and qualitatively
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enhance the power of optogenetics and open distinct avenues of investigation. In particular,
tools are developed that allow targeting of cells solely by virtue of their topological
relationships within tissue and that extend the reach of optical control to the infrared border,
with effector function enhanced beyond the other known tools and covering the entire
visible spectrum.
RESULTS
Membrane Trafficking and Microbial Opsin Genes
Deriving optogenetic tools from multiple classes of microbes promises substantial diversity
of triggering and effector functions (Zhang et al., 2008), given the ecological diversity of
microbial organisms occupying niches with a broad array of environmental signals of
informational or energetic value (Yooseph et al., 2007). Moreover, as a necessary adaptation
to small cell volume and genome size, microbes carry out sensation, transduction, and action
via highly compact mechanisms, often all encompassed within a single open genetic reading
frame (as with the microbial opsins, in which both photon sensation and ion flux effector
function are implemented within a single compact protein) (Kalaidzidis et al., 1998; Lanyi
and Oesterhelt, 1982; Lozier et al., 1975; Nagel et al., 2003). In contrast, metazoan or
vertebrate cells may transduce energy or information with more complex multicomponent
signaling cascades that afford greater opportunities for modulation but are much less
portable (as with the vertebrate opsins). Optogenetic tools from simpler organisms therefore
present clear opportunities, but may not express or be tolerated well by more complex cells.
Indeed, archaeal halorhodopsin (the light-activated electrogenic chloride pump that can be
used for optogenetic inhibition in metazoans) displays impaired subcellular localization
when expressed at high levels in mammalian neurons (Gradinaru et al., 2008; Zhao et al.,
2008). An early trafficking step, export from the endoplasmic reticulum (ER), was found to
be impaired for this first-generation NpHR, leading to intracellular accumulations that
colocalized with the ER marker KDEL (Figure 1A; Figure 1B, left). Fusion of the
FCYENEV ER export motif from a vertebrate inward rectifier potassium channel to the
NpHR C terminus prevented aggregate formation (Figure 1B, center) and greatly enhanced
tolerability at high expression levels.
This second-generation enhanced tool (eNpHR, now eNpHR2.0) has been successfully
employed in vivo and in intact tissue in a number of studies (Gradinaru et al., 2009; Sohal et
al., 2009; Tønnesen et al., 2009; Arrenberg et al., 2009); expression was well tolerated, and
additionally Thy1::eNpHR2.0 mice have been generated with well-tolerated long-term
expression of eNpHR2.0 at high functional levels throughout the brain (G. Feng, G.
Augustine, and K.D., unpublished data). As with many kinds of native inhibition,
optogenetic inhibition could be overcome by strong excitatory activity (Sohal et al., 2009).
Potential additional molecular modifications for enhancing photocurrents from known and
emerging opsin gene family members would include signal peptides, additional ER export
motifs, Golgi trafficking signals, transport signals, and other motifs involved in transport of
membrane proteins along the secretory pathway to the cell surface (Simon and Blobel,
1993). We therefore sought to apply combinatorial membrane trafficking strategies that
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could be generally applicable in a systematic, principled fashion to candidate microbial
membrane proteins for translation to metazoan applications.
Examination of eNpHR2.0-expressing hippocampal neurons revealed the absence of
globular ER accumulations, as previously reported, but nevertheless persistent intracellular
labeling and poor membrane localization (Figure 1B, center), suggesting that additional
modifications subsequent to the ER export step would indeed be important. Examination of
primary-sequence differences between two forms of an inward rectifier potassium channel
with differential membrane localization (Kir2.1 and Kir2.4) revealed differences not only in
C-terminal ER export motifs but also in N-terminal Golgi export signals and in C-terminal
trafficking signals (Hofherr et al., 2005). Surprisingly, we found that provision of the Golgi
export signal did not significantly affect surface expression (data not shown), but that
addition of the trafficking signal from Kir2.1 either between eNpHR and the EYFP fusion,
or at the C terminus of the fusion protein, dramatically reduced intracellular labeling and
increased apparent surface membrane expression (Figure 1B, right) and also improved
labeling of cellular processes (Figure 1B, right). Indeed, high-resolution confocal imaging
(Figure 1C) revealed marked localization in processes, with identifiable labeled membranes
spanning intracellular regions apparently devoid of the opsin-EYFP fusion protein, in a
pattern never previously observed with NpHR or its derivatives.
If improved membrane targeting were indeed achieved with this modification, increased
photocurrents would be anticipated to result. We therefore examined photocurrents, using
whole-cell patch clamp recordings to quantify bona fide functional plasma membrane
localization of halorhodopsin pump molecules. Photocurrents were indeed profoundly
increased (to a level ~20-fold larger than the initially described NpHR currents; mean ±
standard error of the mean [SEM], photocurrent 747.2 ± 93.9 pA in lentivirally transduced
hippocampal pyramidal neurons under the human synapsin I promoter; n = 10; Figure 1D).
At action spectrum peak described below, nanoampere-scale mean outward currents were
readily observed with 3.5 mW/mm2 yellow light, an order of magnitude lower intensity than
required by proton pumps to attain this level of photocurrent (maintaining low light
intensities becomes an important issue only for in vivo experiments, wherein safe control of
significant tissue volumes is paramount) (Aravanis et al., 2007; Adamantidis et al., 2007;
Chow et al., 2010). In virally transduced neurons, light-induced hyperpolarizations by >100
mV were routinely achievable, at the same modest light power levels (mean
hyperpolarization 101.0 ± 24.7 mV; n = 10; Figure 1E). Membrane potential changes of this
new magnitude represent a functionally distinct advance in optogenetic inhibition, and we
accordingly designate this third-generation NpHR as eNpHR3.0 (the Natronomonas
halorhodopsin was named NpHR in 2005 [Sato et al., 2005], and the first trafficking-
enhanced version developed by Gradinaru et al. [2008] is now referred to as eNpHR2.0). As
expected from prior work (Zhang et al., 2007a) showing that NpHR photocurrents were
step-like and exhibited little inactivation over more than 10 min of continuous illumination
(indeed, NpHR was selected for this reason, as described in Zhang et al. [2007a]), the
eNpHR3.0 photocurrents were also step-like, resistant to inactivation, and highly stable over
multiple light pulses and long (behaviorally relevant) timescales (Figure 1D; Figure S1
available online) (Zhang et al., 2007a).
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Targeting by Connection Topology Enabled by Transcellular Trafficking
We asked whether the robust improved expression were preserved in the mammalian brain
in vivo. We injected lentiviral vectors delivering the novel opsin gene under control of the
CaMKIIα promoter to the CA1 region of the hippocampal formation in adult mice and
examined distribution of the expressed EYFP fusion. As in cultured cells, strong expression
was observed not only in dendrites but also in axons in vivo with both eNpHR3.0 and
eNpHR3.1 (a shorter version of eNpHR3.0 with equivalent functionality but the N-terminal
signal peptide removed) (Figure 2A). A major in vivo opportunity for systems neurobiology
would be controlling not just a projection from region A to region B, but a cell type itself
that has (among its connections) a projection from A to B. This fundamentally distinct result
requires multiplexing of optical control with other targeting methods (Figure 2B). Such
control would be of great value in systems neurobiology; for example, cortical excitatory
pyramidal neurons form a genetically and anatomically defined class of cell, but within this
class are cells that each project to multiple different areas of the brain (e.g., thalamus, spinal
cord, striatum, and other cortical areas) and therefore have fundamentally distinct roles
(Lein et al., 2007; Yoshimura et al., 2005). It is unlikely that genetic tools will advance far
enough to separate all of these different cell classes, pointing to the need to inhibit or excite
cell types defined also by connection topology (Figure 2B).
One way to achieve this goal would be to capitalize on transcellular trafficking: to introduce
into the local cell-body location a Cre-dependent virus conditionally expressing the
microbial opsin gene of choice (e.g., Tsai et al., 2009), and rather than additionally
employing a Cre-driver mouse line, to instead introduce into a distant target structure
(chosen to define the cells of interest by anatomical connectivity) a virus expressing Cre
recombinase fused to a transcellular tracer protein, e.g., wheat germ agglutinin (WGA)
(Figure 2B) or tetanus toxin- fragment C (TTC) (Kissa et al., 2002; Maskos et al., 2002;
Perreault et al., 2006; Sano et al., 2007; Sugita and Shiba, 2005). Cre recombinase in the
fusion protein would be transported by presumed endosomal trafficking mechanisms along
with the tracer to the local cell-body location if anatomically connected and activate opsin
expression in the subset of local cells defined by this connectivity (Figure 2B). Note that this
approach does not require any specific promoter fragment or genetic definition of target
cells (a clear advantage for use in less-genetically tractable species such as rats and
primates), as with earlier projection-based targeting methods that are not transcellular
(Gradinaru et al., 2007, 2009; Petreanu et al., 2007, 2009; Lima et al., 2009); but, if needed,
such additional genetic refinements can be readily added (for example, both the WGA-Cre-
and the Cre-dependent opsin could be delivered under control of cell type-specific
promoters where available; Figure 2C), creating a potentially versatile means for addressing
cells defined at the intersection of connectivity, location, and genetics.
We first validated this concept in the rat (Figure 2D) by devising a strategy to selectively
introduce eNpHR3.0 into those primary motor cortex (M1) microcircuits that are involved in
corticocortical connections with primary sensory cortex (S1) (Colechio and Alloway, 2009).
To do this, we injected the previously described Cre-dependent AAV, now conditionally
expressing eNpHR3.0 into motor cortex, and injected a novel WGA-Cre-expressing AAV
(AAV2-EF1α-mCherry-IRES-WGA-Cre) remotely into primary somatosensory cortex.
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Robust eNpHR3.0-EYFP expression was indeed observed in a distributed subset of the
motor cortex neurons (Figure 2D) at 5 weeks after injection, despite the remoteness of the
Cre recombinase AAV injection; in control animals without Cre recombinase, no expression
is observed from these Cre-dependent AAVs (Tsai et al., 2009; Sohal et al., 2009).
Consistent with the anticipated mode of trans-synaptic or transcellular transport of Cre, no
mCherry-positive cell bodies were observed in motor cortex, and no EYFP-positive cell
bodies were observed in S1 sensory cortex (Figure 2D). The expected EYFP-eNpHR3.0
axon terminals arising from M1 were present in S1 (Figure 2D, top right). Simultaneous
optrode stimulation/recording (Gradinaru et al., 2007) was conducted to validate
functionality of eNpHR3.0 under the WGA system; indeed, robust inhibition was readily
observed in M1 (trace in Figure 2D), as expected from the intense fluorescence of the XFP-
opsin fusion protein.
To independently validate this targeting technology in a distinct circuit and with a different
opsin, we next targeted hippocampal formation dentate gyrus neurons involved in
interhemispheric projections (Figure 2E). Within the dentate hilus, the only known
monosynaptic contralateral projection arises from the hilar mossy cells, which terminate on
granule cells of the contralateral dentate, in dendrites of the molecular layer (Figure 2B)
(Freund and Buzsáki, 1996; Ratzliff et al., 2004). The WGA-Cre AAV was unilaterally
injected into one dentate gyrus, while the Cre-dependent AAV was injected into the
contralateral dentate gyrus of the same animal. Strikingly, opsin expression was observed
only in hilar cells of the contralateral side. Indeed, in this case and at this time point,
contralateral dentate accumulation of Cre appeared to extend only to the hilus, as no EYFP
labeling was observed in the contralateral granule cell layer (Figures 2B and 2E). Suggesting
relatively little direct transduction of axon terminals with this AAV serotype, no mCherry
was observed in the contralateral dentate (for cases wherein such direct transduction can and
does occur, robust photosensitization of the incoming projection along with some reduced
specificity of targeting with regard to postsynaptic cell type would be expected to result).
The only EYFP-expressing circuit elements in the ipsilateral dentate, affording precise
opportunities for optical control, were axonal fibers observed to terminate in the molecular
layer of the granule cell layer, precisely as expected for fibers arising from the contralateral
dentate hilus (Figures 2B and 2E). Indeed, in vivo optrode recordings confirmed the
functionality of WGA/Cre-activated ChR2 in driving light-triggered spikes both at the
opsin-expressing cell bodies (Figure 2E) and in neurons downstream to the axonal
projections of ChR2-expressing cells, in the contralateral hemisphere (data not shown); in
line with previous optogenetic studies (Zhang et al., 2007a; Gradinaru et al., 2007, 2009),
473 nm light pulses at 30 Hz (5 ms pulse width) delivered through the optical fiber reliably
drove neuronal firing (Figure 2E) in vivo.
Far-Red Optogenetic Control
The utility of these targeting strategies for engineered opsins within intact tissue raised the
question of whether additional advantages might be accrued with regard to volume of tissue
modulatable in vivo. While membrane trafficking modifications alone will not shift the
action spectrum, the capability to control neurons in the far red is a long-sought goal of
optogenetics, as this will allow use of light that penetrates much more deeply into scattering
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biological tissues (as with the far-red utility recently demonstrated for fluorescent proteins)
(Shu et al., 2009), and therefore will allow recruitment of larger volumes (Aravanis et al.,
2007; Adamantidis et al., 2007; Gradinaru et al., 2009). The massive photocurrents observed
for eNpHR3.0 (~20× those initially reported for NpHR, which itself is capable of blocking
spiking in response to 589 nm amber light), suggested optogenetic control with far-red light
might be achieved. We therefore explored optical control in the far red with the trafficking-
enhanced eNpHR3.0.
Even in response to true-red (630 nm) light of only 3.5 mW/mm2, we observed potent ~250
pA outward photocurrents in virally transduced cells—still more than 6-fold larger than the
first-observed NpHR currents with yellow light (Figure 3A), and maintaining the
characteristic step-like, stable kinetics typical of NpHR (Zhang et al., 2007a) (Figure 1;
Figure S1). Moreover, we found that these photocurrents evoked by red light could be used
to trigger large (>40 mV) hyperpolarizations in hippocampal pyramidal neurons (Figure
3B). We therefore explored even further red-shifted light. We continued to observe robust
photocurrents in the deep red with 660 nm light and at the red/infrared border with 680 nm
light (Figure 3C). Importantly, at all of the red and far-red wavelengths tested, eNpHR3.0
photocurrents readily blocked action potentials induced by current injection (Figure 3D)
with 7 mW/mm2 or less, validating the extension of optogenetic control channels to far-red
light.
One important feature of NpHR is its spectral compatibility with ChR2: the two opsins have
largely separable action spectra and operate with similar light power density requirements,
allowing bidirectional control of optical activity (Zhang et al., 2007a) in vitro or in vivo
despite a small region of spectral overlap. To test whether eNpHR3.0 had become too
potent, given the spectral overlap, to use in combination with ChR2 in the same cell, we
created a bicistronic vector containing eNpHR3.0; analogous 2A-based combination vectors
(Ryan and Drew, 1994) have been employed with earlier tools, and channelrhodopsin
currents with this method have ranged from 150 to 240 pA and halorhodopsin currents from
11 to 40 pA (Tang et al., 2009, Han et al., 2009b). We transfected the eNpHR3.0-2A-ChR2
construct (abbreviated eNPAC) into hippocampal pyramidal neurons. Figure 3E shows that
trafficking of both opsin gene products to cellular processes was observed. To verify that
independent excitation and inhibition was still possible despite the increased currents from
eNpHR3.0, we mapped out the steady-state photocurrent action spectrum in detail for
eNPAC and for ChR2(H134R) (Gradinaru et al., 2007) and eNpHR3.0 alone (Figure 3F).
Maximal eNPAC steady-state excitatory and inhibitory currents were both approximately
60% of that observed when each opsin was expressed individually, yielding maximal
photocurrents of >550 pA in each direction (Figures 3F and 3G); the modestly overlapping
action spectra may provide a feature, in that potent shunting inhibition combined with
hyperpolarizing inhibition is likely possible with this combination approach. Validation in
vivo will require demonstration that the specific P2A method (or other linker approach) is
functional in a particular circuit or cell type (yet to be determined); however, these data in
cultured hippocampal neurons demonstrate that potent bidirectional photocurrents of >500
pA each can be achieved within a single cell, without incapacitating interference of the
trafficking-enhanced opsin.
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Optical Inhibition in the Green and Blue Enabled by Cellular and Genomic Tools
The known wide action spectrum of the microbial opsins (Figure 3) poses challenges with
regard to achieving multiple independent channels of control; interestingly, eNpHR3.0
becomes not only a potent far-red optical control tool, but also the most potent known blue
light-driven opsin-based inhibitor (>400 pA at 472 nm; Figure 3F). Indeed, the membrane
trafficking strategies delineated here may form a generalizable strategy for adapting diverse
microbial opsins with unique properties for optogenetic control purposes. In a final series of
experiments, we explored whether these and other enhanced membrane trafficking
principles could enable the addition of genetically and functionally distinct components to
the optogenetic toolbox.
While a very large number of microbial opsins genes exist in nature, we and others have
thus far found none that outperform eNpHR3.0 (as described herein) with regard to
photocurrent size, light requirements, or kinetics (Zhang et al., 2007a; Han and Boyden,
2007; Chow et al., 2010). It is important to continue to expand the optogenetic toolbox, but
we have found that most microbial opsins traffic poorly in mammalian cells (Figure 4;
Figure S2). However, application of the trafficking principles for microbial opsin
engineering outlined here may enable optogenetics to continue the genomics progress over
the past few years (Zhang et al., 2008), capitalizing on the immense natural diversity of
microbial opsins (Zhang et al., 2008; Chow et al., 2010). We sought to test the adaptability
of the membrane trafficking principle with the best-characterized microbial opsin,
bacteriorhodopsin (BR) (Stoeckenius and Bogomolni, 1982), from H. salinarum, a green
light-activated regulator of transmembrane ion conductance (Marti et al., 1991).
We found that expressed in unmodified form, prominent intracellular accumulations were
observed, similar to those seen when the Natronomonas halorhodopsin is expressed at high
levels (Figure 4A, top left), and no photocurrents were observed. However, addition of the
trafficking signal (TS, as employed for eNpHR3.0) between BR and EYFP substantially
improved membrane and process localization (Figure 4A, top right), with smaller persistent
ER-like accumulations that were eliminated with further C-terminal addition of the ER
export signal FCYENEV (Figure 4A, center row). The resulting construct (eBR, doubly
engineered for optimal membrane trafficking) was well tolerated in cultured neurons, with
marked membrane localization and process targeting (Figure 4A, center right and bottom
row). Validation of functional plasma membrane targeting revealed that eBR could typically
deliver ~50 pA of outward photocurrent (Figure 4B) and ~10 mV hyperpolarizations (Figure
4C) that sufficed to block spiking in hippocampal pyramidal neurons when exposed to the
optimal wavelength light of 560 nm (Figure 4D), thereby providing another channel for
optogenetic control and illustrating the potential generalizeability of the microbial opsin
membrane trafficking approach.
We also continued genomic strategies similar to those that allowed our identification of the
red-shifted excitatory opsin VChR1 from Volvox carteri (Zhang et al., 2008); indeed, a
number of microbes have been reported to display light sensitivities from violet to near
infrared. We accordingly continued our broad genomic mining approach in environmental
sequencing databases, plant/microbial expressed sequence tag (EST) libraries, and whole-
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genome shotgun (WGS) sequencing repositories to search for new rhodopsins with channel
or pump properties and novel light sensitivities (Zhang et al., 2008). Using the primary
amino acid sequences for ChRs, HRs, and BRs as the template sequence, we continued the
search among evolutionarily distant species (Zhang et al., 2008; Chow et al., 2010). Among
other candidate sequences from diverse hosts (Cryptomonas, Guillardia, Mesostigma,
Dunaliella, Gloeobacter, etc.), one of these from Guillardia theta was different from the
previously reported GtR1 and GtR2 (Sineshchekov et al., 2005) and showed high amino acid
homology to ChR2. We designated this new protein as G. theta rhodopsin-3 (GtR3, Figure
S2A), optimized the codon bias of GtR3 for mammalian expression, and delivered the GtR3-
EYFP fusion gene to hippocampal pyramidal neurons. In an emerging theme, GtR3 showed
intracellular accumulations (Figure S2B, left) and no photocurrents. Provision of the TS
signal between GtR3 and EYFP only mildly reduced accumulations (Figure S2B, middle),
but, together with addition of the ER export signal FCYENEV to the C terminus (Figure
S2B, right), accumulations were abolished and increased surface and process localization
observed. The resulting modified GtR3 hyperpolarizes hippocampal neurons (Figure S2C,
left) in response to 472 nm blue light, albeit with smaller currents than eBR (Figure S2C,
right), and could inhibit spiking as well (Figure S2D). We also achieved blue inhibition of
spiking with an opsin (AR) from Acetabularia acetabulum (Tsunoda et al., 2006; Chow et
al., 2010) engineered for improved trafficking; AR generates little current alone but was
initially aggregate free and required only addition of the TS signal between AR and EYFP
for functional membrane localization and spike inhibition (Figure S2E).
While these and other published microbial opsin-derived inhibitors are not yet as potent as
eNpHR3.0 (and for this reason we continue with eNpHR3.0 for optogenetic applications),
the improved functionality achieved here by membrane trafficking modifications point to the
potential versatility of this approach in unlocking the full potential of ecological diversity,
and to the individualized strategies that will be indicated for different microbial opsin genes
(Figure 5).
DISCUSSION
Single-component optogenetic approaches previously have found substantial utility in the
control of biological processes and behavior in freely moving mammals (Adamantidis et al.,
2007; Airan et al., 2009; Gradinaru et al., 2009; Petreanu et al., 2007, 2009; Sohal et al.,
2009; Tsai et al., 2009) and other animals (Douglass et al., 2008; Hwang et al., 2007; Zhang
et al., 2007a), with the high temporal precision that is important for intact-systems biology.
We have found that engineering specific membrane-trafficking capabilities for microbial
proteins is an important step in generating diverse optogenetic technologies for intact-
systems biology. Not all trafficking strategies will be suitable for all microbial opsins, with
different motifs required for opsins that encounter trafficking difficulty at different stages;
therefore, careful subcellular analysis with rational selection of proper modifications
together constitute a directed and principled strategy that may be applicable to all opsins of
non-mammalian origin, thereby enabling systematic generation of novel optogenetic tools
from genomic resources (Figure 5).
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eNpHR3.0: New Quantitative Properties and New Classes of Application
We have previously observed that inhibition with NpHR and NpHR2.0, while useful for
many applications (Gradinaru et al., 2009; Sohal et al., 2009; Tønnesen et al., 2009;
Arrenberg et al., 2009), can in some cases be overcome by very strong excitation (Sohal et
al., 2009). Hyperpolarizations by greater than 100 mV (Figure 1) with eNpHR3.0 provide a
substantial step forward in the potency of optical inhibition. The inhibition now provided
with eNpHR3.0, more than 20-fold stronger than the initial NpHR, remains tunable with
light intensity or duty-cycle adjustments, as with any of the optogenetic tools. At the action
spectrum peak, nanoampere-scale mean outward currents readily resulted (Figure 3F, right)
with only 3.5 mW/mm2 yellow light (10-fold less light power than required for approaching
similar currents with previously described proton pumps). At the same time, eNpHR3.0
preserved the step-like kinetics, fast recovery, and resistance to inactivation over long
timescales of NpHR (Zhang et al., 2007a) (Figure S1; Figures 1 and 3).
eNpHR3.0 is particularly well suited for in vivo applications, as the most red-shifted and
potent optogenetic inhibitor to date, but further strategies to enhance potency of this and
other tools will no doubt emerge, and membrane trafficking work as described here may
enable even more potent inhibitors in the future. When employing eNpHR3.0, inhibition can
be readily dialed down if needed by using weaker promoters, shorter expression times, or
reduced light levels, while maintaining access to new wavelengths ~100 nm red-shifted from
previous reports (680 nm versus 589 nm; Figure 3) to enable operating at the infrared border
with deeper-penetrating and safer photons. Of course, not only the opsin gene and light
source selected, but also the strategy for circuit element targeting, may determine
effectiveness; for example, optogenetic work on Parkinsonian models (Gradinaru et al.,
2009) showed that therapeutically effective deep brain stimulation (DBS) in the subthalamic
nucleus (STN) is likely initiated by action on afferent axons (which in turn then modulate
both downstream and upstream networks). While direct fiberoptic-based inhibition of local
cell bodies in the STN did not show behavioral effects comparable to those observed with
direct modulation of afferent axons, these results do not mean that inhibition of the STN is
not important (indeed, optogenetic axonal modulation in the STN results in inhibition of
STN spiking, as noted by Gradinaru et al. [2009]). Rather, these results informed the long-
standing clinical significant questions surrounding the mechanism and target of DBS by
showing that axonal modulation constitutes the likely therapeutic mechanism and a highly
efficient means for a point source such as a DBS electrode (or optical fiber) to control a
structure or network in diseased neural circuitry (Gradinaru et al., 2009). In addition to these
circuit element targeting considerations, the light intensity and wavelength, promoter choice,
virus titer, virus tropism, time of opsin expression, target cell biophysics, and local patterns
of endogenous activity and modulation will all affect optogenetic inhibition efficacy and
should be carefully considered for each experimental system (Cardin et al., 2010; Zhang et
al., 2010).
Tissue-Topology Targeting for Optogenetics
To enable control of cell types on the basis of connectivity properties, we developed a Cre
recombinase-based two-virus strategy (Figure 2) in which cells were targeted with well-
tolerated AAV methods without use of cell type-specific promoter fragments or transgenic
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animals. In each system, this approach must be validated for directionality (antero- or
retrograde) and extent of Cre transport, which may depend on cell-specific endosomal
dynamics and experimental timepoint; this strategy may also work only with viruses rather
than mouse transgenesis, allowing Cre access to episomal DNA. The dual-virus approach
described here capitalizes upon the high efficiency and long-term tolerability of AAVs while
also enabling robust optical control (Figures 2D and 2E) via catalytically driven activation
of high copy-number transgenes. It is important to be aware that direct transduction of axon
terminals with certain viruses can be achieved for targeting (reviewed in Callaway, 2008),
and indeed virtually all viruses (including AAVs) carry some degree of this capability in a
serotype- and circuit-dependent manner, as we and others have observed (Burger et al.,
2004; Paterna et al., 2004; Callaway, 2008; Lima et al., 2009; Passini et al., 2005;
Nathanson et al., 2009). It is also important to consider (in the process of selecting viruses)
the need for high levels of infection and expression while avoiding adverse effects on
transduced neurons over weeks to months for long-term electrophysiological or behavioral
experiments.
As shown in Figure 2, the cell-process targeting enabled by membrane trafficking
modification allows for control of cells that are defined topologically—that is, by the
essential character of their connections within tissue. At present, it is not guaranteed that
transport is synaptic or monosynaptic (as in the hippocampal circuit experiments in Figure 2,
such properties will need to be validated in each system); therefore, the term “topological
targeting” rather than synaptic targeting is here used to underscore the deformation
independence of the fundamental character of the connection—an axonal connection can
take any path from A to B, and as long as the connection is present, the topological targeting
strategy remains valid. This property is important in genetically less-tractable organisms, but
also of substantial value even in animals such as mice, where genetic targeting tools are in
many cases inadequate. Of course, genetic targeting strategies may be multiplexed with
topological targeting; for example, expression from the Cre-dependent vector and the Cre-
fusion vector (Figure 2C) may each be governed by specific genetic targeting sequences if
available. Moreover, the availability of multiple channels of optical control opens the door
to combinatorial topological targeting strategies.
Avenues for Technology Development and Application
Like ChR2, NpHR, and VChR1, we note that most microbial opsins can benefit from
substantial protein engineering to achieve new kinds of functionality. Indeed, we and others
have previously demonstrated molecular strategies for eliciting from microbial opsins
increased light sensitivity (Berndt et al., 2009), increased photocurrent magnitude
(Gradinaru et al., 2007, 2008; Zhao et al., 2008), faster kinetics (Gunaydin et al., 2010; Lin
et al., 2009), and bistable switching behavior (Berndt et al., 2009). Other possibilities such
as shifted action spectrum (Zhang et al., 2008; Gunaydin et al., 2010), increased two-photon
responsivity, and altered ion permeability (e.g., for Ca2+) may also be achieved in the future.
While ion conductance-regulating opsins have been the most versatile for ready translation
(employing a common electrical language), biochemical control with light in defined cell
types is also possible (but with a different set of approaches, given that microbial signal
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transduction employs principles distinct from metazoan signaling). Indeed, optogenetic
control of well-defined biochemical signaling pathways was recently achieved both in
cultured cells and in freely moving mammals, using the optoXR method for optical control
of specified G protein-coupled receptor signaling (Airan et al., 2009). A photoactivatable
adenylyl cyclase has been studied from Euglena, although with high dark activity that limits
in vivo application (Schröder-Lang et al., 2007), and subsequent work on light-sensitive
PAS or LOV domains (Levskaya et al., 2009; Wu et al., 2009) may open up new ways to
control protein-protein association if these approaches can be made to operate in living
animals.
We have found that in the nervous system, optogenetic tools can be applied to probe the
neural circuit underpinnings of information transmission, oscillations, locomotion,
awakening, and reward, as well as to probe the operation of neural circuits important in a
number of brain diseases including Parkinson’s disease and epilepsy (Adamantidis et al.,
2007; Airan et al., 2009; Cardin et al., 2009; Gradinaru et al., 2009; Sohal et al., 2009;
Tønnesen et al., 2009; Tsai et al., 2009). Moroever, results thus far point to substantial
versatility of the optogenetic approach across animal species (Adamantidis et al., 2007;
Airan et al., 2009; Aravanis et al., 2007; Arenkiel et al., 2007; Bi et al., 2006; Boyden et al.,
2005; Chow et al., 2010; Douglass et al., 2008; Gradinaru et al., 2008, 2009; Hägglund et
al., 2010; Han et al., 2009a; Huber et al., 2008; Hwang et al., 2007; Ishizuka et al., 2006; Li
et al., 2005; Nagel et al., 2003; Petreanu et al., 2007, 2009; Tsai et al., 2009; Wang et al.,
2007; Zhang et al., 2006, 2007a; Zhang and Oertner, 2007; Zhao et al., 2008). Together with
fiberoptic (Adamantidis et al., 2007; Aravanis et al., 2007) and integrated fiberoptic-
electrode “optrode” assemblies (Gradinaru et al., 2007), even cells located deep within large,
dense organs can be readily accessed and interrogated in freely moving mammals. The
additional resources defined here arise from the application of molecular, cellular, and
genomic strategies to enable expansion of the capabilities of optical control, and, as this
toolbox rapidly grows, optogenetics may come to play an increasingly potent and versatile
role in intact-systems biology for the fast control of defined cells within functioning tissues.
EXPERIMENTAL PROCEDURES
Constructs
All NpHR variants were produced by PCR amplification of the NpHR-EYFP construct
previously published (Zhang et al., 2007a). All opsins described here have been optimized
for mammalian expression by changing each gene’s codon usage to conform to human
codon usage distribution. Updated maps and vectors are freely distributed from the
Deisseroth laboratory and described at http://www.optogenetics.org/.
Hippocampal Cultures
Primary cultured hippocampal neurons were prepared from P0 Spague-Dawley rat pups. The
CA1 and CA3 regions were isolated, digested with 0.4 mg/ml papain (Worthington,
Lakewood, NJ), and plated onto glass coverslips precoated with 1:30 Matrigel (Beckton
Dickinson Labware, Bedford, MA) at a density of 65,000/cm2. Hippocampal cultures grown
on coverslips were transfected or transduced at 4 days in vitro (DIV) with titer-matched
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viruses for all constructs (final dilution 104 infectious units (i.u.)/ml in neuronal growth
medium). Whole-cell patch clamp recordings were performed as previously described
(Zhang et al., 2007a). At 14 DIV, cultures were fixed for 30 min with ice-cold 4%
paraformaldehyde and then permeabilized for 30 min with 0.4% saponin in 2% normal
donkey serum (NDS). Primary antibody incubations were performed overnight at 4°C; Cy3-
conjugated secondary antibodies (Jackson Laboratories, West Grove, PA) were applied in
2% NDS for 1 hr at room temperature. Images were obtained on a Leica confocal
microscope with a 63×/1.4 NA oil objective.
Stereotactic Injection into the Rodent Brain and Optrode Recordings
Adult mice and Long-Evans rats were housed according to the approved protocols at
Stanford. All surgeries were performed under aseptic conditions. The animals were
anesthetized with intraperitoneal injections of a ketamine (80 mg/kg)/xylazine (15–20
mg/kg) cocktail (Sigma). The virus was delivered via a 10 μl syringe and a thin 34 gauge
metal needle; the injection volume and flow rate (1 μl at 0.1 μl/min) were controlled with an
injection pump from World Precision Instruments (Sarasota, FL). For validation of opsin
functionality, simultaneous optical stimulation and electrical recording in living rodents was
conducted as described previously (Gradinaru et al., 2007) with an optrode composed of an
extracellular tungsten electrode (1 MΩ, ~125 μm) attached to an optical fiber (~200 μm)
with the tip of the electrode deeper (~0.4 mm) than the tip of the fiber to ensure illumination
of the recorded neurons. The optical fiber was coupled to a 473 nm (for ChR2) or 560 nm
(for eNpHR3.0) laser diode (10 mW fiber output) from CrystaLaser. Optrode recordings
were conducted in rodents anesthetized with 1.5% isoflurane, and the optode was placed
through small craniotomies created above target regions. pClamp 10 and a Digidata 1322A
board were used to both collect data and generate light pulses through the fiber. The
recorded signal was band-pass filtered at 300 Hz low/5 kHz high (1800 Microelectrode AC
Amplifier).
Tissue Slice Preparation
For preparation of brain slices, mice or rats were sacrificed 4 to 5 weeks after viral injection.
Rodents were perfused with 20 ml ice-cold PBS, followed by 20 ml 4% paraformaldehyde.
The brains were then fixed overnight in 4% paraformaldehyde and transferred to 30%
sucrose solution for 2 days. Brains were frozen and coronal slices (40 μm) were prepared
with a Leica SM2000R cryostat and preserved in 4°C in cryoprotectant (25% glycerol and
30% ethylene glycol in PBS). Slices (DAPI stain 1:50,000) were mounted with PVA-
DABCO on microscope slides, and single confocal optical sections (e.g., through dorsal
CA1 region, ~1–2.5mm posterior to bregma or the dorsal subiculum, 2.7–3 mm posterior to
bregma) were acquired using a 10× air and 40×/1.4 NA oil objectives on a Leica confocal
microscope.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Multiple Trafficking Modules for Microbial Opsin Function in Mammalian Neurons
(A) Hippocampal neurons showing wild-type NpHR-EYFP aggregation in the ER. NpHR
(green) and ER (red; immunostaining of the KDEL marker) are also shown in overlay
(yellow) to illustrate colocalization of NpHR aggregates and ER (arrows, ER; arrowheads,
ER aggregates).
(B) Multistep modification of wild-type NpHR (left) rescues membrane expression.
Addition of the K-channel ER export motif (eNpHR2.0, middle) and trafficking signal
(eNpHR3.0, right) respectively reduced ER aggregation and improved membrane expression
(particularly in neuronal processes for 3.0).
(C) Membrane expression enabled in processes for eNpHR3.0 (confocal images showing
membrane-localized EYFP fluorescence in the soma [top] and dendrite [inset, bottom]).
(D) Representative traces (left) showing photocurrents in cells virally transduced with
eNpHR3.0 (black) and eNpHR2.0 (gray). Summary plot (right) showing average
photocurrent levels in cells expressing eNpHR3.0 (747.2 ± 93.9 pA) and eNpHR2.0 (214.1
± 24.7 pA; unpaired t test p < 0.0005; n = 10). Values plotted are mean ± SEM. Membrane
input resistance was similar for all neurons patched (eNpHR2.0: 193.1 ± 36.6 MΩ;
eNpHR3.0: 151.6 ± 28.5 MU; unpaired t test p = 0.37). Light delivery (593 nm) is indicated
by the yellow bar.
(E) Representative traces (left) showing voltage traces in cells virally transduced with
eNpHR3.0 (black) and eNpHR2.0 (gray). Summary plot (right) showing average
hyperpolarization levels in cells expressing eNpHR3.0 (101.0 ± 24.7 mV) and eNpHR2.0
(57.2 ± 6.8 mV; unpaired t test p < 0.0005; n = 10).
See also Figure S1.
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Figure 2. Trafficking-Enhanced Projection Targeting and Topological Targeting In Vivo
(A) Lentiviral delivery of eNpHR3.1 (shorter version of eNpHR3.0 with the N-terminal
signal peptide removed; Experimental Procedures) driven by the CaMKIIα promoter led to
expression in CA1 pyramidal neurons and dendrites (top; arrowhead indicates CA1), as well
as in axon terminals (bottom; arrowhead indicates subiculum).
(B) Transcellular gene activation by wheat germ agglutinin (WGA)-Cre fusion. The
schematic depicts two injection sites (one with WGA-Cre fusion gene and another with Cre-
dependent opsin virus) and long-range projections; Cre can be transcellularly delivered from
transduced cells (red) to activate distant gene expression only in connected neurons that
have received the Cre-dependent virus (green), not in others (gray).
(C) Construct design for the WGA-Cre (top) and Cre-dependent (bottom) AAV vectors.
WGA and Cre genes are both optimized with mammalian codons.
(D) Injection of AAV carrying the EF1α::mCherry-IRES-WGA-Cre cassette in the rat
primary somatosensory cortex (S1) led to mCherry fluorescence in neuronal somata at the
injection site (top left), but, as expected, not in distant motor cortex (M1, bottom left).
Injection of Cre-inducible AAV5-EF1α::eNpHR3.0-EYFP into the ipsilateral motor cortex
(M1) led to opsin expression (EYFP fluorescence) in M1 somata (bottom right), but, as
expected, in S1, eNpHR3.0-EYFP was seen only in projecting axon terminals from these
M1 cells (dispersed green puncta), not in somata (top right). Optrode recordings in vivo
from the M1 site (560 nm light; bottom trace).
(E) The two dentate gyri were injected with AAV2-EF1a-mCherry-IRES-WGA-Cre (left)
and AAV8-EF1a-DIO-ChR2-EYFP (right). Lower panels show high-magnification images
of boxed regions above. Cells transduced with WGA-Cre expressed mCherry as expected
(red), almost entirely within the granule cell layer (GCL) delineated by DAPI fluorescence
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(blue). WGA-Cre activated Cre-dependent opsin expression (EYFP fluorescence) in the
contralateral hilus (arrowhead), a known source of projections to the ipsilateral dentate (note
that on the contralateral side, EYFP fluorescence was confined to the hilus as expected; top
right). This projection from the contralateral hilus is known to synapse on dentate granule
cells in the molecular layer (Ratzliff et al., 2004), which in turn is visible as a thin green
strip of opsin-EYFP expression bordering the GCL (ML, top left). Optrode extracellular
recordings during optical stimulation (30 Hz, 5 ms, 473 nm) confirmed functional in vivo
opsin expression in dentate neurons expressing ChR2-EYFP (bottom trace).
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Figure 3. Far-Red Optogenetic Inhibition and Single-Component, Bidirectional Optical Control
(A) Six hundred thirty nanometer light evokes robust photocurrents in neurons transduced
with eNpHR3.0 (representative voltage clamp trace at left). Summary plot comparing
eNpHR2.0- and eNpHR3.0-expressing neurons (at right); eNpHR2.0, 42.7 ± 4.5 pA;
eNpHR3.0, 239.4 ± 28.7 pA; unpaired t test p = 0.00004; n = 10).
(B) Six hundred thirty nanometer illumination evoked robust hyperpolarization
(representative voltage clamp trace at left). Summary plot comparing eNpHR2.0- and
eNpHR3.0-expressing neurons (right); 15.6 ± 3.2 mV for eNpHR2.0 and 43.3 ± 6.1 mV for
eNpHR3.0; unpaired t test p = 0.00116; n = 10).
(C) Summary of outward photocurrents evoked by different wavelengths of red and far-red/
infrared border illumination: 630 nm, 239.4 ± 28.7 pA (left, n = 10); 660 nm, 120.5 ± 16.7
pA (middle, n = 4); and 680 nm: 76.3 ± 9.1 pA (right, n = 4). Power density: 3.5 mW/mm2
(630 nm) and 7 mW/mm2 (660 nm, 680 nm).
(D) Illumination with red and far-red/infrared border light inhibited spiking induced by
current injection in neurons expressing eNpHR3.0. Typical current-clamp traces show
optical inhibition at 630 nm (top left), 660 nm (top right), and 680 nm (bottom). Power
density: 3.5 mW/mm2 (630 nm) and 7 mW/mm2 (660 nm, 680 nm).
(E) eNpHR 3.0-EYFP (left) and hChR2-mCherry (middle) expressed both on the neuronal
membrane and throughout the neurites.
(F) Activation spectrum for eNPAC (left), and for ChR2(H134R) (right, blue) and
eNpHR3.0 (right, yellow) alone. Maximum eNPAC steady-state excitation was 567 ± 49 pA
at 427 nm (n = 9), 62% of the value for ChR2(H134R) alone (916 ± 185 pA; n = 5).
Similarly, maximum eNPAC inhibition was 679 ± 109 pA at 590 nm (n = 9), 61% of the
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value for eNpHR3.0 alone (1110 ± 333 pA; n = 4). Output power density for peak
eNpHR3.0 current values was 3.5–5 mW/mm2 (3.5 mW/mm2 at 590 nm).
(G) Blue light (445 nm, 5 ms pulses) drove spiking at 20 Hz (left) and 10 Hz (right), while
simultaneous application of yellow light (590 nm) inhibited spikes.
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Figure 4. eBR: Trafficking-Enhanced Tool for Green Inhibition
(A) Confocal images in hippocampal neurons: unmodified BR forms aggregates similar to
those of unmodified NpHR (top left). Provision of the TS motif before EYFP decreased
aggregate size but did not fully eliminate aggregates (top right). Only when the ER export
motif (FCYENEV) was also added to the C terminus were aggregates abolished, resulting in
good membrane targeting throughout the soma (middle panels) and far into processes
(bottom panels).
(B) Five hundred sixty nanometer light (green bar) induced outward photocurrents in eBR
cells (left, sample trace in voltage clamp), 46.4 ± 7.2 pA (right bar graph). Mean ± SEM is
plotted, n = 12. Membrane input resistance was similar for all neurons patched (131.6 ± 19.5
mΩ). Light power density at sample was 7 mW/mm2.
(C) Corresponding light-induced hyperpolarizations (left, sample trace in current clamp)
were 10.8 ± 1.0 mV (right bar graph). Mean ± SEM is plotted, n = 12.
(D) Illumination with green light (560 nm) sufficed to inhibit current injection-induced
spiking.
See also Figure S2.
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Figure 5. Optogenetics: Molecular Design for Microbial Tools
(A) General subcellular targeting strategies for adapting microbial opsin genes to metazoan
intact-systems biology.
(B) Refinement of targeting at the tissue and subcellular levels. Subcellular opsin targeting
methods have been previously described (for various dendritic compartment strategies, see
Gradinaru et al. [2007] and Lewis et al., [2009]), and tissue/transcellular opsin targeting
methods are described in Figure 2.
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